MedPath

Agreement between transcutaneous and serum bilirubin in infants =35 weeks POG

Not Applicable
Conditions
Health Condition 1: K768- Other specified diseases of liver
Registration Number
CTRI/2024/04/065826
Lead Sponsor
COMMAND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Infants born at = 35 weeks POG with clinical hyperbilirubinemia with Transcutaneous bilirbin within 3mg/dl of phototherapy range as per Bhutani chart 2022

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath